The CD83 reporter mouse elucidates the activity of the CD83 promoter in B, T, and dendritic cell populations in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 33, 2008, Pages 11887-11892

  Lechmann, Matthias ^a   Shuman, Naomi ^a   Wakeham, Andrew ^a   Mak, Tak W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Immune system; Intravital microscopy; Mouse model

Indexed keywords

CD83 ANTIGEN; LIGAND; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL MATURATION; CELL MIGRATION; CELL POPULATION; CELL TYPE; CONTROLLED STUDY; DENDRITIC CELL; EX VIVO STUDY; GENE ACTIVITY; GENE IDENTIFICATION; IMMUNOSTIMULATION; IN VIVO STUDY; LYMPHOCYTIC INFILTRATION; LYMPHOID ORGAN; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN VARIANT; REPORTER GENE; SEQUENCE HOMOLOGY; STEADY STATE; T LYMPHOCYTE; TRANSLATION REGULATION; UPREGULATION;

ANIMALS; ANTIGENS, CD; B-LYMPHOCYTES; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MEMBRANE; CELLS, CULTURED; DENDRITIC CELLS; GENES, REPORTER; IMMUNOGLOBULINS; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES;

MURINAE; MUS;

EID: 50149089762     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0806335105     Document Type: Article

References (38)

1. Lanzavecchia A, Sallusto F (2001) Antigen decoding by T lymphocytes: From synapses to fate determination. Nat Immunol 2:487-492.
2. Lanzavecchia A, Sallusto F (2001) Regulation of T cell immunity by dendritic cells. Cell 106:263-266.
3. Sallusto F, Lanzavecchia A (2002) The instructive role of dendritic cells on T-cell responses. Arthritis Res 4(Suppl 3):S127-S132.
4. Zhou LJ, Schwarting R, Smith HM, Tedder TF (1992) A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J Immunol 149:735-742.
5. Zhou LJ, Tedder TF (1995) Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J Immunol 154:3821-3835.
6. Weissman D, et al. (1995) Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc Natl Acad Sci USA 92:826-830.
7. Zhou LJ, Tedder TF (1995)Adistinct pattern of cytokine gene expression by human CD83 blood dendritic cells. Blood 86:3295-3301.
8. + dendritic cells. Proc Natl Acad Sci USA 93:2588-2592.
9. Wolenski M, et al. (2003) Enhanced activation of CD83-positive T cells. Scand J Immunol 58(3):306-311.
10. + T cell longevity in vivo. J Immunol 179:4550-4562.
11. Kozlow EJ, Wilson GL, Fox CH, Kehrl JH (1993) Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood 81:454-461.
12. Breloer M, et al. (2007) CD83 is a regulator of murine B cell function in vivo. Eur J Immunol 37:634-648.
13. + T cell development in the thymus. Cell 108:755-767.
14. + T cells. J Immunol 173:2995-3001.
15. McKinsey TA, Chu ZL, Tedder TF, Ballard DW (2000) Transcription factor NF-κB regulates inducible CD83 gene expression in activated T lymphocytes. Mol Immunol 37:783-788.
16. Berchtold S, et al. (2002) Cloning and characterization of the promoter region of the human CD83 gene. Immunobiology 205:231-246.
17. Ohta Y, et al. (2004) Homologs of CD83 from elasmobranch and teleost fish. J Immunol 173:4553-4560.
18. Berchtold S, et al. (1999) Cloning, recombinant expression, and biochemical characterization of the murine CD83 molecule which is specifically up-regulated during dendritic cell maturation. FEBS Lett 461:211-216.
19. Twist CJ, Beier DR, Disteche CM, Edelhoff S, Tedder TF (1998) The mouse Cd83 gene: Structure, domain organization, and chromosome localization. Immunogenetics 48:383-393.
20. Hock BD, Kato M, McKenzie JL, Hart DNJ (2001) A soluble form of CD83 is released from activated dendritic cells and B lymphocytes and is detectable in normal human sera. Int Immunol 13:959-967.
21. Lechmann M, Kremmer E, Sticht H, Steinkasserer A (2002) Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodies. Protein Expression Purif 24:445-452.
22. Dudziak D, Nimmerjahn F, Bornkamm GW, Laux G (2005) Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation. J Immunol 174:6672-6676.
23. Luthje K, et al. (2006) Transgenic expression of a CD83-immunoglobulin fusion protein impairs the development of immune-competent CD4-positive T cells. Eur J Immunol 36:2035-2045.
24. +. Blood 107:1528-1536.
25. Aerts-Toegaert C, et al. (2007) CD83 expression on dendritic cells and T cells: Correlation with effective immune responses. Eur J Immunol 37:686-695.
26. Lechmann M, et al. (2001) The extracellular domain of CD83 inhibits dendritic cellmediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 194:1813-1821.
27. Scholler N, et al. (2002) Cutting edge: CD83 regulates the development of cellular immunity. J Immunol 168:2599-2602.
28. Zinser E, Lechmann M, Golka A, Lutz MB, Steinkasserer A (2004) Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J Exp Med 200:345-351.
29. Xu JF, et al. (2007) A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts. Transpl Int 20:266-276.
30. Jang SK, et al. (1988) A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol 62:2636-2643.
31. Wolenski M, et al. (2003) Expression of CD83 in the murine immune system. Med Microbiol Immunol 192:189-192.
32. Suh WK, et al. (2003). The B7 family member B7-H3 preferentially down-regulates Thelper type 1-mediated immune responses. Nat Immunol 4:899-906.
33. Klein E, et al. (2005) CD83 localization in a recycling compartment of immature monocytederived dendritic cells. Int Immunol 17:477-487.
34. Cao W, Lee SH, LU J (2005) CD83 is preformed inside monocytes, macrophages, and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem J 385:85-93.
35. Kuwano Y, et al. (2007) CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells. Int Immunol 19:977-1002.
36. - dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192:1685-1696.
37. + T cells involving acquired MHC class II:peptide complexes: Another mechanism to limit clonal expansion? Blood 101:2704-2710.
38. Lutz MB, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223:77-92.